Lilly’s offering is expected to surpass Novo’s Wegovy in the space, and, according to a report this week from GlobalData, it ...

According to key opinion leaders, positive SURMOUNT-5 results, alongside Lilly’s business strategy, means Zepbound is set to ...

Operational risks are also reduced due to a lesser need for human intervention in hazardous environments, which is a very ...

GlobalData looks at whether the The Donald will build on the power production revolution he began during his first term.

These digitalisation initiatives could provide long-term benefits to the oil and gas industry, says GlobalData. GlobalData’s ...

It’s become evident that a cloud-based IT portfolio brings organisations the greatest promise for providing the type of ...

In a release sent to Rigzone recently, GlobalData said the oil and gas industry has seen a dip in active jobs in 2024 but ...

KOLs interviewed by GlobalData stressed the lack of biologic therapies specifically targeting T2-low asthma.

Virtual reality primarily has applications around training across the oil and gas value chain,' GlobalData said.

Current treatments for chronic hand eczema (CHE) generally fall into two buckets: Either they battle inflammation but lead to ...

AI-driven adaptive cardiac devices are revolutionizing heart disease treatment by enabling real-time monitoring and dynamic ...

Eli Lilly's Zepbound is challenging Wegovy in the obesity market, while U.S. health care costs are set to rise 9% in 2025, driven by specialty drugs and inflation.